Offerings (SEC Form D)
Each filing as reported by the issuer, newest first. Open a row for the full plain-English detail. D = original notice, D/A = amendment.
Offerings at a glance — 3 offerings, 3 filings (one row per SEC file number)
| File no. | Original Form D | Latest filing | Amendments | Offered (latest) | Sold (latest) | Industry (latest) |
|---|
| 021-592460 | Jul 29, 2026 EDGAR ↗ | Jul 29, 2026 D EDGAR ↗ | 0 | $645,000 | $600,000 | Other Health Care |
| 021-536517 | Jan 28, 2025 EDGAR ↗ | Jan 28, 2025 D EDGAR ↗ | 0 | $3,000,000 | $1,999,998 | Other Health Care |
| 021-465490 | Nov 21, 2022 EDGAR ↗ | Nov 21, 2022 D EDGAR ↗ | 0 | $8,224,458 | $8,224,458 | Other Health Care |
Offerings are grouped by SEC file number; rows without a file number (not yet retrieved from EDGAR) are shown as their own offering until the link is fetched.
Jul 29, 2026 D Other Health Care — $600,000 sold of $645,000 · 8 investors EDGAR ↗
| Filing | Form D filed Jul 29, 2026SEC file no. 021-592460 · accession 0001955339-26-000002 |
| Raise progress | $600,000 sold of $645,000 offered (93%) · $45,000 remaining · first sale Jul 24, 2026 |
| Filing timing | Date of first sale: Jul 24, 2026 · Form D filed: Jul 29, 2026 (5 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 92 days (0.3 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 8 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $12,092 |
| Securities offered | Debt; Security to be acquired upon exercise |
| Entity details | Organized in DELAWARE · formed 2022 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | SHARA COHEN, CEO (Jul 29, 2026) |
| Market context | Minimum investment: $12,092. Typical range for similar offerings: $10,000–$54,310. Offering size: $645,000. Typical range: $829,831–$9,999,998. Investors: 8. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
Jan 28, 2025 D Other Health Care — $1,999,998 sold of $3,000,000 · 10 investors EDGAR ↗
| Filing | Form D filed Jan 28, 2025SEC file no. 021-536517 · accession 0001955339-25-000002 |
| Raise progress | $1,999,998 sold of $3,000,000 offered (67%) · $1,000,002 remaining · first sale Jan 17, 2025 |
| Filing timing | Date of first sale: Jan 17, 2025 · Form D filed: Jan 28, 2025 (11 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 645 days (1.8 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 10 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $36,000 |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2022 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Shara Cohen, President (Jan 28, 2025) |
| Market context | Minimum investment: $36,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $3,000,000. Typical range: $829,831–$9,999,998. Investors: 10. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
Nov 21, 2022 D Other Health Care — $8,224,458 sold of $8,224,458 · 24 investors EDGAR ↗
| Filing | Form D filed Nov 21, 2022SEC file no. 021-465490 · accession 0001955339-22-000001 |
| Raise progress | $8,224,458 sold of $8,224,458 offered (100%) · $0 remaining · first sale Nov 7, 2022 |
| Filing timing | Date of first sale: Nov 7, 2022 · Form D filed: Nov 21, 2022 (14 days after first sale) Rule: a Form D is generally due within 15 days after the first sale. Both dates are shown as reported; no conclusion is drawn. |
| Time since first sale | 1,447 days (4.0 years) |
| Annual amendments | Issuer reported the offering is not expected to last more than one year. No amendment for this offering in our index (filings 2008 → Oct 22, 2026; checked Oct 23, 2026, 5:45 PM ET). Rule: an ongoing offering generally files an amendment at least annually. Dates shown as reported; no conclusion is drawn. |
| Investors | 24 total · issuer reported no non-accredited investors |
| Exemption claimed | Rule 506(b) — no general advertising; up to 35 non-accredited investors allowed |
| Minimum investment accepted | $25,000 |
| Securities offered | Equity |
| Entity details | Organized in DELAWARE · formed 2022 · revenue range: Decline to Disclose (state and year as reported on the issuer's latest filing) As reported by the issuer on Form D (Items 1–2 and 5). |
| Industry | Other Health Care |
| Who is paid to sell it | No sales compensation recipients listed on this filing. |
| Money to insiders | Sales commissions: $0 · Finder's fees: $0 · Proceeds to officers, directors, promoters: $0 |
| Signed by | Shara Cohen, President (Nov 21, 2022) |
| Market context | Minimum investment: $25,000. Typical range for similar offerings: $10,000–$54,310. Offering size: $8,224,458. Typical range: $829,831–$9,999,998. Investors: 24. Typical range: 2–15."Similar" = Other Health Care, Rule 506(b). Based on 4,189 Form D filings 2021–2026 in the same industry and exemption (Other Health Care, Rule 506(b); original Form D notices, one per offering) (Form D data, SEC). Ranges are the middle half (25th–75th percentile) of the filings that reported each value: minimum investment 1,330, offering size 3,970, investors 3,669. Computed by PartnerFacts as of Oct 23, 2026, 5:45 PM ET. No ranking or score. Source: PartnerFacts data & coverage. |
| Source | This filing on SEC EDGAR ↗ · retrieved from the SEC Form D bulk data set · PartnerFacts data last updated Oct 23, 2026, 5:45 PM ET |
All Form D filings for this CIK on SEC EDGAR ↗. History: 1 new offering in the last 12 months (new offering = a Form D that is not an amendment) · most recent filing Jul 29, 2026. Industry as reported, by offering: All 3 offerings reported: Other Health Care (2022–2026).
Key people 5
Officers, directors and promoters the issuer itself named on its Form D. Tap a name for every other deal they are on.
| Name | Relationship | Address state | On filings (first → last) | Also listed on |
|---|
| EC Emma Cartmell | Director | IL | Jan 28, 2025 → Jul 29, 2026 on 2 of 3 filings listed on the latest filing | — |
| JB John Banta | Director | IL | Nov 21, 2022 → Jul 29, 2026 on 3 of 3 filings listed on the latest filing | 7 other issuers |
| MP Maria Perrin | Director | IL | Jul 29, 2026 on 1 of 3 filings listed on the latest filing | — |
| SC Shara Cohen | Executive Officer, Director Issuer's note: President and CEO | IL | Nov 21, 2022 → Jul 29, 2026 on 3 of 3 filings listed on the latest filing | — |
| TJ Todd Johnson | Director | IL | Nov 21, 2022 → Jul 29, 2026 on 3 of 3 filings listed on the latest filing | 2 other issuers |
Executive officers, directors and promoters as self-reported by the issuer, one row per person. Spellings of the same name (same first and last name, or the same full name that EDGAR split differently into middle and last name) with no conflicting middle initial are shown on one row (none on this issuer); dates and counts come from the filings that list each name. Licensed persons: FINRA BrokerCheck ↗ · SEC IAPD ↗.
Connections
Other issuers listing the same people:
- Auxira Health, Inc. — Todd Johnson · latest filing Nov 4, 2025
- BlueCross BlueShield Venture Partners V, LLC — John Banta · latest filing Aug 15, 2025
- S1 Seed Ventures I, LP — Todd Johnson · latest filing Jun 18, 2024
- AUTONOMIC MATERIALS, INC. — John Banta · latest filing Jan 14, 2022
- BlueCross BlueShield Venture Partners IV, LLC — John Banta · latest filing Mar 16, 2020
- BLUECROSS BLUESHIELD VENTURE PARTNERS III, LLC — John Banta · latest filing May 25, 2017
- TetraVitae Bioscience, Inc. — John Banta · latest filing Oct 14, 2010
- Illinois Emerging Technologies Fund II, LP — John Banta · latest filing Apr 12, 2010
- iCyt Mission Technology Inc — John Banta · latest filing Jun 10, 2009
Shared address: this business address appears on filings for 1 other issuer. Stated as a count only (suite numbers ignored) — many addresses are shared office buildings or registered agents. As of Oct 23, 2026, 5:45 PM ET.
Other offering types (Regulation A and Regulation Crowdfunding)
Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.
Adviser registration (Form ADV)
Searched SEC Form ADV bulk data (registered + exempt reporting advisers) (24,962 records as of Oct 2, 2026, 8:00 AM ET) — nothing matched Carallel, Inc..
Meta advertising
No Meta Pixel ids or Facebook / Instagram page links on file for Carallel, Inc. as of Oct 24, 2026 — the sponsor website is read for them once it is on file (runs automatically). Meta Ad Library: not searched by PartnerFacts (no API access); a one-tap Ad Library search is under Look further.
Public profiles
Public profiles official links and public statements, each with its source and date
No website or social profile named in Carallel, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #16,029 of 374,652 in line (14 issuers searched so far).
Sources searched for a website: Form C data set (issuer websites as filed), Form ADV data set (Item 1.I of matched advisers) — as of Oct 23, 2026, 11:20 PM ET: none on file for this issuer. The sponsor website, the Internet Archive and GDELT news index are read only once a site is on file; a sponsor's website comes from the issuer's own filings (Form C issuer website; EDGAR company profile), an approved profile claim, Form ADV Item 1.I of its matched adviser, or a web search for the issuer name confirmed on the site's own homepage. We never collect personal or family accounts.
Entity standing: not checked (no official programmatic source for IL yet).
Export this report as PDF (all source links + data timestamp) · Premium
Request diligence pack (Premium) PartnerFacts asks the sponsor for the standard information pack and delivers it to you labelled "provided by the sponsor".
Corrections log
No corrections have been requested for this page.
Filing-to-filing changes are in Amendment history above.
Email me the full report
The complete public-record profile for Carallel, Inc., plus the weekly new-filings list.
What do you want to do?
Only "Connect me" shares your details — with this sponsor, at a flat price we charge them, never tied to whether you invest. "Just researching" shares nothing.
Request a correction
Free. Tell us what's wrong and, if you can, where the correct public record is. Every request is logged with its status (received → under review → fixed / confirmed with source).